Lanchantin G F, Presant C A, Hart D W, Friedmann J A
Division of Laboratories, Cedars Division, Cedars-Sinai Hospitals, Los Angeles, California, USA.
Thromb Diath Haemorrh. 1965 Sep 1;14(1-2):159-75.
A comparison has been made between the clotting activity (C) and TAMe esterase activity (E) during prothrombin activation and subsequent purification of human thrombin. A limited number of studies were made using bovine thrombin for comparison purposes. Under certain circumstances, the ratio of C to E for human thrombin is not constant, particularly upon gel-filtration at low ionic strength and during prolonged contact with 25% sodium citrate. Under other circumstances, however, these enzymic parameters are stable and human thrombin appears to have a ratio of C to E of approximately 6 while bovine thrombin has a ratio of 3. This finding may confirm the observations of others concerning the higher specific activity of human thrombin than the bovine enzyme against bovine fibrinogen. Only a single component having C and E activity has been isolated from human prothrombin preparations activated to thrombin by sodium citrate or biologically and purified by either gel filtration or ion exchange chromatography. Kinetic studies on human thrombin preparations indicate that in all other respects they are similar in enzymic properties to those reported for the purified bovine enzyme.
在凝血酶原激活及随后的人凝血酶纯化过程中,对凝血活性(C)和对甲苯磺酰-L-精氨酸甲酯(TAMe)酯酶活性(E)进行了比较。为作比较,使用牛凝血酶进行了有限数量的研究。在某些情况下,人凝血酶的C与E之比并非恒定,尤其是在低离子强度下进行凝胶过滤时以及与25%柠檬酸钠长时间接触期间。然而,在其他情况下,这些酶学参数是稳定的,人凝血酶的C与E之比似乎约为6,而牛凝血酶的该比值为3。这一发现可能证实了其他人关于人凝血酶相对于牛酶对牛纤维蛋白原具有更高比活性的观察结果。从经柠檬酸钠激活至凝血酶并通过凝胶过滤或离子交换色谱法进行生物纯化的人凝血酶原制剂中,仅分离出一种具有C和E活性的成分。对人凝血酶制剂的动力学研究表明,在所有其他方面,它们在酶学性质上与报道的纯化牛酶相似。